Asked by: Lord Alton of Liverpool (Crossbench - Life peer)
Question to the Home Office:
To ask His Majesty's Government what assessment they have made of legislating to provide that British National (Overseas) visa holders are not subject to immigration control; and what plans they have to grant holders of British National (Overseas) status a statutory right of abode in the United Kingdom.
Answered by Lord Hanson of Flint - Minister of State (Home Office)
The Government remains steadfast in its support for members of the Hong Kong community in the UK and is fully committed to the British National (Overseas) (BN(O) route, which will continue to welcome Hong Kongers. We confirmed in the earned settlement consultation document A Fairer Pathway to Settlement (CP1448) that those on the BN(O) route will retain a five-year route to settlement. We have no plans to legislate to create a right of abode for BN(O)s, or to otherwise exempt them from immigration control.
Asked by: Lord Alton of Liverpool (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how many yellow card reports of (1) tinnitus (Medical Dictionary for Regulatory Activities (MedDRA) code 10043882), and (2) worsening of tinnitus (MedDRA code 10048029), the Medicines and Healthcare products Regulatory Agency received in each year since 2014, and what medications those reported were linked to.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring medicines, medical devices, and blood components for transfusion meet applicable standards of safety, quality, and efficacy. The MHRA rigorously assesses the available data, including from the Yellow Card scheme, and seeks advice from the Commission on Human Medicines, the MHRA’s independent advisory committee, where appropriate, to inform regulatory decisions, including amending the product information.
The MHRA has received a total of 11,348 United Kingdom based reports through the Yellow Card scheme associated with reaction term tinnitus, including worsening of tinnitus, from 1 January 2014 up to and including 27 November 2025. The reports received between 2014 and 2025 were for a wide range of medicinal products which include antidepressants, hormonal medicines, vaccines, antipsychotics, antibiotics, cardiovascular medicines, drugs used to treat attention deficit hyperactivity disorder, sedatives, drugs used to treat dementia and diabetes, drugs used to treat osteoporosis, Parkinson’s disease, and pain. The following table shows a yearly breakdown of reports associated with tinnitus, from 2014 to 2025, and in total:
Year | Number of reports |
2014 | 147 |
2015 | 164 |
2016 | 230 |
2017 | 206 |
2018 | 197 |
2019 | 205 |
2020 | 212 |
2021 | 7,208 |
2022 | 1,248 |
2023 | 578 |
2024 | 495 |
2025 | 458 |
Total | 11,348 |
It is important to note that anyone can report to the MHRA’s Yellow Card scheme and the recording of these reports in the Yellow Card database does not necessarily mean that the adverse reactions have been caused by the suspect drug. Many factors must be considered in assessing causal relationships, including temporal association, the possible contribution of concomitant medication, and the underlying disease. We encourage reporters to report suspected adverse reaction reports, and the reporter does not have to be sure of a causal association between the drug and the reactions, as a suspicion will suffice.
The number of reports received cannot be used as a basis for determining the incidence of a reaction, as neither the total number of reactions occurring, nor the number of patients using the drug, is known. All fatal reports, including those reporting completed suicide, are assessed by the MHRA, and cumulative information is reviewed at regular intervals.
Asked by: Lord Alton of Liverpool (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how many yellow card reports of visual snow syndrome (Medical Dictionary for Regulatory Activities code 10079450) the Medicines and Healthcare products Regulatory Agency received in each year since 2014, and what medications those reports were linked to.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring medicines, medical devices, and blood components for transfusion meet applicable standards of safety, quality, and efficacy. The MHRA rigorously assesses the available data, including from the Yellow Card scheme, and seeks advice from the Commission on Human Medicines, the MHRA’s independent advisory committee, where appropriate, to inform regulatory decisions, including amending the product information.
The MHRA has received a total of 44 United Kingdom based reports through the Yellow Card scheme associated with the reaction term visual snow syndrome received up to and including 25 November 2025. The table attached shows the yearly breakdown of substances associated with visual snow syndrome, each year from 2017 to 2025.
It is important to note that anyone can report to the MHRA’s Yellow Card scheme, and the recording of these reports in the Yellow Card database does not necessarily mean that the adverse reactions have been caused by the suspect drug. Many factors must be considered in assessing causal relationships, including temporal association, the possible contribution of concomitant medication, and the underlying disease. We encourage reporters to report suspected adverse reaction reports, and the reporter does not have to be sure of a causal association between the drug and the reactions, as a suspicion will suffice.
The number of reports received cannot be used as a basis for determining the incidence of a reaction, as neither the total number of reactions occurring, nor the number of patients using the drug, is known. All fatal reports, including those reporting completed suicide, are assessed by the MHRA and cumulative information is reviewed at regular intervals.
Asked by: Lord Alton of Liverpool (Crossbench - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what steps they are taking to coordinate with other governments efforts to strengthen existing bilateral sanctions and impose additional sanctions to prevent the sale and transfer of aviation fuel to Burma; whether they support the establishment of an aviation fuel embargo and the enforcement of a global arms embargo on the government of Burma through the UN Security Council; and whether they are taking steps to communicate the risk of potential criminal liability to companies involved in the government of Burma’s aviation-fuel supply chain.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
We continue to support the aspirations of the people of Myanmar for a peaceful, democratic future. Any meaningful election needs to be accompanied by an end to violence, a resumption of dialogue among all parties concerned, and must also address the urgent need to allow access for humanitarian assistance, to end human rights violations, and reverse the collapse of public services. We will continue to engage international partners, including ASEAN and at the UN Security Council, on the challenges facing people in Myanmar. On 19 November at the UN Third Committee meeting on Myanmar, the UK delivered a statement, reiterating concern for human rights violations and election plans: https://www.gov.uk/government/speeches/the-uk-is-concerned-by-the-ongoing-violence-in-myanmar-including-escalating-human-rights-violations-and-increasing-reports-of-sexual-andgender-based
Since 2021, the UK Government has enacted 19 sanctions packages against the Myanmar regime, including 10 individual sanctions targeting the import of aviation fuel into Myanmar. In 2022 the UK updated our Overseas Business Risk Guidance to make it clear that UK businesses should conduct thorough supply chain diligence to ensure that commodities such as aviation fuel do not reach the military.
We have also sanctioned 25 individuals and 39 entities targeting the regime's access to finance, arms and equipment. We keep all evidence and potential designations under close review. It would not be appropriate to speculate about potential future sanctions designations as to do so could reduce their impact.
Asked by: Lord Alton of Liverpool (Crossbench - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what discussions they have had with (1) the Association of South-East Asian Nations (ASEAN), and (2) the outgoing and incoming chairs of ASEAN, namely the governments of Malaysia and the Philippines, regarding the human rights situation in Burma, and the forthcoming elections proposed by the government of Burma.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
We continue to support the aspirations of the people of Myanmar for a peaceful, democratic future. Any meaningful election needs to be accompanied by an end to violence, a resumption of dialogue among all parties concerned, and must also address the urgent need to allow access for humanitarian assistance, to end human rights violations, and reverse the collapse of public services. We will continue to engage international partners, including ASEAN and at the UN Security Council, on the challenges facing people in Myanmar. On 19 November at the UN Third Committee meeting on Myanmar, the UK delivered a statement, reiterating concern for human rights violations and election plans: https://www.gov.uk/government/speeches/the-uk-is-concerned-by-the-ongoing-violence-in-myanmar-including-escalating-human-rights-violations-and-increasing-reports-of-sexual-andgender-based
Since 2021, the UK Government has enacted 19 sanctions packages against the Myanmar regime, including 10 individual sanctions targeting the import of aviation fuel into Myanmar. In 2022 the UK updated our Overseas Business Risk Guidance to make it clear that UK businesses should conduct thorough supply chain diligence to ensure that commodities such as aviation fuel do not reach the military.
We have also sanctioned 25 individuals and 39 entities targeting the regime's access to finance, arms and equipment. We keep all evidence and potential designations under close review. It would not be appropriate to speculate about potential future sanctions designations as to do so could reduce their impact.
Asked by: Lord Alton of Liverpool (Crossbench - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what assessment they have made of the forthcoming elections in Burma, in particular whether they will be free or fair.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
We continue to support the aspirations of the people of Myanmar for a peaceful, democratic future. Any meaningful election needs to be accompanied by an end to violence, a resumption of dialogue among all parties concerned, and must also address the urgent need to allow access for humanitarian assistance, to end human rights violations, and reverse the collapse of public services. We will continue to engage international partners, including ASEAN and at the UN Security Council, on the challenges facing people in Myanmar. On 19 November at the UN Third Committee meeting on Myanmar, the UK delivered a statement, reiterating concern for human rights violations and election plans: https://www.gov.uk/government/speeches/the-uk-is-concerned-by-the-ongoing-violence-in-myanmar-including-escalating-human-rights-violations-and-increasing-reports-of-sexual-andgender-based
Since 2021, the UK Government has enacted 19 sanctions packages against the Myanmar regime, including 10 individual sanctions targeting the import of aviation fuel into Myanmar. In 2022 the UK updated our Overseas Business Risk Guidance to make it clear that UK businesses should conduct thorough supply chain diligence to ensure that commodities such as aviation fuel do not reach the military.
We have also sanctioned 25 individuals and 39 entities targeting the regime's access to finance, arms and equipment. We keep all evidence and potential designations under close review. It would not be appropriate to speculate about potential future sanctions designations as to do so could reduce their impact.
Asked by: Lord Alton of Liverpool (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government when post-selective serotonin reuptake inhibitors sexual dysfunction (PSSD) was added as a yellow card reporting option; who requested it and why; and whether the Medicines and Healthcare products Regulatory Agency plans to update PSSD reports made before the addition of that option with the MedDRA code 10086208.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring medicines, medical devices, and blood components for transfusion meet applicable standards of safety, quality, and efficacy. The MHRA rigorously assesses available data, including from the Yellow Card scheme, and seeks advice from their independent advisory committee, the Commission on Human Medicines, where appropriate to inform regulatory decisions.
The MHRA uses the Medical Dictionary for Regulatory Activities (MedDRA) to code suspected adverse drug reactions reported by patients and healthcare professionals via the Yellow Card scheme. MedDRA is an international, clinically validated medical terminology used by regulatory authorities and the biopharmaceutical industry throughout the entire regulatory process, from pre-marketing to post-marketing safety monitoring. MedDRA is updated twice annually, and new terms can be proposed by any MedDRA users. The term Post Selective Serotonin Reuptake Inhibitor Sexual Dysfunction (PSSD) was added to MedDRA as a lower-level term in version 24.1 which was and implemented by the MHRA as a term available to users of the Yellow Card website in February 2022 as part of routine updates.
As part of current routine MHRA processes, Yellow Card reports are not recoded to reflect the changes in the reaction terms available but remain as reported with the terms selected by the original reporter.
As a lower-level term in MedDRA, PSSD is recorded if the reporter has specifically used this term at the time of the report, and since this term can include a wide range of symptoms it would not be appropriate to recode cases not reporting this specific term received prior to 2021. All Yellow Card reports received prior to the availability of PSSD as a MedDRA term will have the individual symptoms reported coded as MedDRA terms and available for signal detection and assessment processes.
Asked by: Lord Alton of Liverpool (Crossbench - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what recent representations they have made to the government of Nigeria on ensuring protection of Christians, especially in the middle belt and north of Nigeria; what response they have received; and whether they plan to review extant UK arms export licences to Nigeria.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
I refer the Noble Lord to the answer I provided on 24 November to Question HL11756.
Asked by: Lord Alton of Liverpool (Crossbench - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what support they provide to civil-society and faith-based organisations in Nigeria working to address religiously-targeted violence.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
I refer the Noble Lord to the answer I provided on 24 November to Question HL11756.
Asked by: Lord Alton of Liverpool (Crossbench - Life peer)
Question to the Ministry of Justice:
To ask His Majesty's Government when and how they intend to respond to the report by the Children's Commissioner "A production line of pointlessness": Children on custodial remand, published on 11 November.
Answered by Lord Timpson - Minister of State (Ministry of Justice)
The Government recognises the importance of the Children’s Commissioner’s report and shares concerns about the number of children remanded to custody. We have taken steps to address this, including publishing the Youth Remand Concordat earlier this year to help all partners meet their statutory responsibilities and work effectively together throughout the bail and remand process. We are also supporting local authorities to tackle this issue, for example, by continuing to fund the Greater Manchester remand pilot to enable regional pooling of remand funding, supporting the development of alternatives to custodial remand. Reducing unnecessary remands to custody remains a priority, and we will set out further plans in due course.